Likewise, another study on hepatocellular carcinoma has revealed that an MYH9/GSK3β/β-catenin/c-Jun regulatory circuit improves cancer stemness, migration, invasion, and resistance to sorafenib. This evidence concerns the gene MYH9 and cancer.